A comparison of four technologies for detecting p53 aggregates in ovarian cancer

The tumor suppressor protein p53 is mutated in half of all cancers and has been described to form amyloid-like structures, commonly known from key proteins in neurodegenerative diseases. Still, the clinical relevance of p53 aggregates remains largely unknown, which may be due to the lack of sensitiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinzl, Nicole, Koziel, Katarzyna, Maritschnegg, Elisabeth, Berger, Astrid, Pechriggl, Elisabeth, Fiegl, Heidi, Zeimet, Alain G., Marth, Christian, Zeillinger, Robert, Concin, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493009/
https://www.ncbi.nlm.nih.gov/pubmed/36158680
http://dx.doi.org/10.3389/fonc.2022.976725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493009/
https://www.ncbi.nlm.nih.gov/pubmed/36158680
http://dx.doi.org/10.3389/fonc.2022.976725

Ejemplares similares